BeiGene (BGNE) Receives a Hold From Bernstein
TipRanksApr 25 03:45 ET
BeiGene Analyst Ratings
BenzingaApr 24 13:24 ET
BeiGene Analyst Ratings
BenzingaApr 8 12:33 ET
Bernstein Adjusts BeiGene's Price Target to $161 From $196, Maintains Market Perform Rating
MT NewswiresMar 27 06:25 ET
BeiGene Analyst Ratings
BenzingaMar 27 04:47 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE) and BeiGene (BGNE)
TipRanksMar 26 19:50 ET
BeiGene: Hold Recommendation Amidst Mixed Financial Indicators and Robust Drug Pipeline Growth
TipRanksMar 15 08:25 ET
UBS Cuts BeiGene Stock Target to $285.70, Maintains Buy Rating
InvestingFeb 29 10:32 ET
Analysts Are Bullish on These Healthcare Stocks: Athira Pharma (ATHA), BeiGene (BGNE)
TipRanksFeb 28 00:10 ET
BeiGene Analyst Ratings
BenzingaFeb 27 12:01 ET
BeiGene Hold Rating Upheld Amid Revenue Growth and Market Challenges
TipRanksFeb 27 07:18 ET
BeiGene: Balancing Robust Zanubrutinib Sales and Financial Challenges – A Hold Rating
TipRanksFeb 27 02:25 ET
Brukinsa's Market Dominance and BeiGene's Promising Pipeline Fuel Buy Rating and New Price Target
TipRanksFeb 26 16:45 ET
Analysts Are Bullish on Top Healthcare Stocks: BeiGene (BGNE), McKesson (MCK)
TipRanksFeb 26 07:20 ET
BeiGene Hold Rating Maintained Amid Mixed Drug Sales and Revised Financial Risk Profile
TipRanksFeb 19 05:45 ET
Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), BeiGene (BGNE) and Catalent (CTLT)
TipRanksFeb 12 08:20 ET
BeiGene Analyst Ratings
BenzingaFeb 6 08:56 ET
Analysts Are Bullish on These Healthcare Stocks: BeiGene (BGNE), Travere Therapeutics (TVTX)
TipRanksJan 25 06:50 ET
BeiGene's Hold Rating: Balancing BGB-16673's Promise With Market Realities
TipRanksJan 12 04:06 ET
Leerink Partners Sticks to Its Buy Rating for BeiGene (BGNE)
TipRanksJan 11 01:41 ET
No Data
No Data